SCHEMBL5116438

SCHEMBL5116438

CCC(=O)Nc1cc(Cl)cc(COc2c(Cl)cc(CC(=O)O)cc2Cl)c1F

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRB P10828 11/20 0.51
THRA P10827 10/20 0.51
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
TSHR P16473 1/20 0.38
MAPT P10636 2/20 0.34
ABL1 P00519 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
RIN1 Q13671 1/20 0.34
MAPK1 P28482 1/20 0.34
P2RX3 P56373 1/20 0.34
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722481 0.91 THRA (0.44) THRBTHRAMEN1KMT2AALDH1A1
SCHEMBL5112221 0.91 THRB (0.53) THRBTHRAMEN1KMT2AALDH1A1
SCHEMBL5117297 0.91 THRB (0.50) THRBTHRAMEN1KMT2AALDH1A1
SCHEMBL5104608 0.90 THRA (0.40) THRBTHRAMEN1KMT2AALDH1A1
SCHEMBL5111931 0.89 THRB (0.40) THRBTHRAMEN1KMT2AKDM4E
SCHEMBL5115648 0.87 THRB (0.53) THRBTHRAMEN1KMT2AALDH1A1
SCHEMBL4926650 0.87 THRB (0.40) THRBTHRAMEN1KMT2AMAPT
SCHEMBL4929450 0.87 THRB (0.41) THRBTHRAMEN1KMT2ATSHR
SCHEMBL5118962 0.86 THRA (0.53) THRBTHRAMEN1KMT2AALDH1A1
SCHEMBL4933925 0.85 THRB (0.39) THRBTHRAMEN1KMT2ACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA THRB 4/4885THRA 3/4885MEN1 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.